We postulate that MTTs have diff erentiating purpose, structure, and processes rooted in team organization principles taken from both business and academic environments ( Table 3 ) .
MTT Goals/Purpose
Th e principal goal of an MTT is to develop and apply new knowledge to improvements in human health. Th e purposes of the MTT span accelerated product development, education and training, improvement of internal teamwork skills, leadership development, and team adaptation. A stated goal of the CTSA (and that of MTTs) is increasing the pace at which diagnostic procedures and new therapeutics are brought to bear on human health. In this respect, MTTs are similar to New Product Teams in industry. 35, 36 Training and education imperatives include trainee development, leadership skills, and team-based capabilities, 17, 37 consistent with the CTSA Education and Training Key Function Committee recommended competencies which include leading multidisciplinary teams, facilitating innovation, and fostering creativity. 37 Development of teamwork skills improves team eff ectiveness. [38] [39] [40] Finally, teams that learn, adapt, and self-correct become more eff ective and innovative over time. [41] [42] [43] Th is capacity to adapt in both scientifi c and organizational domains is paramount given the dynamic nature of translational science.
Attributes from business teams applicable to MTT development
In our consideration of team development for translational science, we reviewed three distinct academic team types 5 , 19-25 and five business team types. [26] [27] [28] [29] [30] [31] [32] [33] Although there is a rich literature in business and industry which describes the value of many diff erent types of teams, 26, 29, 31, 32, 34 less is known about team science in AHCs. 1,6,7 , 11-14 Table 1 illustrates the goals, structure, and processes unique to each type. None of the existing team types satisfy the unique combination of attributes of MTTs (highlighted in Table 1 ) .
From this comparison, we identifi ed attributes from fi ve business team types that are most appropriate to incorporate into an MTT design. Th e formally designated roles and leadership and objective evaluation criteria characteristic of a Traditional Task/Project Team constitute a strategic core and provide metrics for assessing translational product development ( Table 2 ) . Th e focus on innovation characteristic of an industry-based New Product Design Team is necessary for an MTT to develop new approaches to diagnostic or therapeutic development. Multidisciplinary scientific paradigms in Cross-Functional Teams inform the structure of an MTT. Technological mediation to enable data visualization and team management in Virtual Teams are applicable to MTTs. Finally, egalitarian governance and transformational leadership characteristic of Self-Managed Teams are attributes of MTTs that align with academic pursuits. 
MTT structure
Innovative translational research spans a range of expertise, knowledge and tasks in the clinical research continuum. Incorporation of multiple disciplines leads to increased eff ectiveness and innovation. [44] [45] [46] Many types of disciplinary interactions (referred to as "interdisciplinarity," "multidisciplinarity," and "transdisciplinarity") have roles in team-based translational research, 13 but an argument can be made that multidisciplinarity may be the most eff ective form. First, multidisciplinarity does not require a fully integrated or new discipline be developed to approach a translational project. In the translational continuum, the requirement for specifi c disciplines and expertise vary not only as a function of team goals, but also with time as the project develops. Second, multidisciplinarity is more time effi cient than what a full interdisciplinarity approach would demand. Th is effi ciency better facilitates the MTT goal of accelerated product development. For both of these reasons, we propose that an essential organizing structure of an MTT is that it be legitimately multidisciplinary.
MTTs, as in business Traditional Task/Project Teams, are based on a strategic core structure ( Figure 1 ). 47 Th e roles within the MTT strategic core would be academically defi ned, and could include a principal investigator, other collaborating scientists from multiple disciplines, a project manager, and trainees. Th e strategic core may change over time as projects are initiated and concluded; these dynamic changes infl uence collaboration and performance within the team.
Th e strategic core of an MTT interacts with both internal and external networks of collaborators, which gives rise to increased team eff ectiveness and innovation. Th ese external networks may include other universities and research centers, independent labs, pharmaceutical labs and companies, governmental labs and agencies, as well as key functions such as bio-repositories, biostatistics, and/or clinical research centers provided by a CTSA or other institutional structure. As the team matures and projects progress, diff erent individuals and networks may engage, disengage and reconfi gure its structure as required for progressing along the T1-T3 translational continuum. • Accelerated innovation and discovery to address human disease • Translation to population based health outcomes Table 3 . Design considerations for the establishment of MTT. The specifi c structure, processes, and functioning of an MTT will differ based on its goals, its membership, and the design features summarized here.
MTT processes
features for team performance. 48, 49 Collaboration is an academic tradition characteristic of individual laboratories, associated with high performing science teams. 50 Here, collaboration is both a process and a product. It is a process in that specifi c members are chosen and engaged for a given project, and is a product in that such collaboration renders commitment, trust, and team cohesion over time.
Interdependence also distinguishes MTTs from other team types. Considerable research indicates that interdependent, heterogeneous, and diverse teams are more innovative 44, 51 and effective. 52 Thus, incorporating processes that foster interdependence and diversity of expertise is a key feature of the MTT.
Egalitarian governance and technological facilitation are additional diff erentiating components of an MTT. Nondirect leadership structures that stress transformational principles such as overall goals, criticality of mission, and alignment of interest with broader institutional goals is critical in eff ective researchbased teams. 53, 54 Given the potential geographic dispersion of many core team members and external collaborators, technologic facilitation may be another essential component of MTTs. Team success is dependent on eff ective transfer of knowledge and information typical of scientifi c groups. Recent evidence suggests such facilitation is predictive of knowledge production and team innovation. 55, 56 MTT adaptive evolution MTTs evolve and mature quite diff erently than traditional business teams. A considerable literature details specifi c stages and phases of business team maturation. While MTTs may progress through distinct phases, it is also likely that, because of the dynamism of translational goals, the requirements of scientifi c collaboration, and the time variance of MTT network collaborations, MTT team development will not be linear, and hence its development is not aligned with traditional business teams. Team development and evolution occurs as a result of time-based adaptations as well as disruptive and revolutionary quantum changes. Here, science teams, such as MTTs, may experience long periods of inertia punctuated by disruptive change, such as radical changes in funding, or scientifi c breakthroughs. We postulate that MTTs exist in no less than four distinct phases or stages. Because of the degree of multidisciplinarity, changing membership, and contextual factors, we propose that MTTs are never at a state of full maturity, but rather are in a constant state of reconfi guration and redeployment ( Figure 2 ). Th is model is quite distinct from that of an industry team, in which the product focus constrains the extent of reconfi guration. In an MTT, each stage may be completed, only to reenter a previously mastered stage due to changes in team project, structure, or goals. Hence, our model is a dynamic process beginning with identifi cation of a translational science opportunity or need, followed by establishment of a strategic core and network collaborators, followed by team orientation (creation of identity, goals, roles, and structural agreements), and lastly by team collaboration, scientific exchange, and full engagement and productivity aligned with translational goals. Such dynamic stages have theoretical justifi cation from the literature, as teams learn and evolve over time, and may require substantively diff erent lengths of time to reach maturity. 
Instantiation of MTTs at UTMB

Team design characteristics
Our literature analysis suggests that at least thirty team design characteristics are important to the function of MTTs. Th ese features can be aggregated into the domains of context, tasks, membership, skill acquisition, team development, team structure, team processes, team reactions and aff ective states, team evolution and development, and team performance criteria ( Table 3 ). An optimal MTT design will incorporate aspects of each of these domains ( Table 4) . To place the above discussion in practical terms, we will illustrate the UTMB environment for MTTs, how MTTs are operationalized and describe the development of two distinct MTTs as Case Illustrations.
Contextual factors
Interdisciplinary research teams at UTMB predate the development of the NIH roadmap 57 by over two decades. Accordingly, the academic context in which our MTTs were developed likely shares important features with other academic health centers. In the late 1980s, UTMB made the strategic decision to use institutional and foundation funds to develop and support thematically focused interdisciplinary research centers. Within each center, a core nucleus of scientists produce scientific discovery relevant to the center's focus. Research themes are identifi ed by center faculty who develop consensus during research retreats and by identifying strategic opportunities. Resources are then used to recruit and develop additional faculty and for equipment for core laboratories within the center. Center members are jointly appointed in appropriate academic departments. Currently six active centers are supported by the university on topics such as Molecular Medicine (and Systems Biology), Environmental Health and Medicine, Structural Biology and Molecular Biophysics, Vaccine Development, Cancer and Cell Biology.
Th e Centers use the institutional funding to support successful new extramural funding in the form of multi-investigator (P01 and Center) grants and to stimulate new innovative themes that can themselves become Centers. To support the Center model, the university has developed mechanisms for multiple (joint) center-and department affi liations that have resulted in a culture of multidisciplinary faculty collaborations. Because of the central role that Core Resource Laboratories played in Center operations, formal Academic Promotion and Tenure (APT) criteria were revised with specifi c wording for the evaluation of scholarly activities, which now includes specifi c criteria for independent scholarly and creative contributions, collaborative research accomplishments, and exceptional facilitation of the work of many others. Th is latter criterion is oft en accomplished by core resource support that is essential for translational research in biostatistics, genomics, proteomics, and bioinformatics.
Oversight and support for university-wide core laboratories is by a broad-based faculty committee (University Core Development Committee) that proactively assesses the needs for new technologies and encourages adoption of best practices. Th is process of multi-investigator research initiated by Centers has created a fertile environment for developing MTTs.
Operationalizing MTTs in the UTMB CTSA The UTMB center structure positioned the CTSA to apply the hybrid industry-academic MTT model. The UTMB CTSA is organized into 12 Key Functions (Key Resources) linked by a central point of contact (Coordination Core). MTTs are competitively selected for CTSA support through peer review by our Scientific Review Committee. Review criteria include the theme, rigor of the proposed science, qualities of the principal investigator(s), projected impact of the translational project, and involvement of trainees ( Table 5 ). MTTs are ultimately approved by our Executive Committee. Institutional structures that have broad based resources at other institutions could conceivably serve the infrastructural support needs that our CTSA provides.
Currently the CTSA portfolio includes 11 distinct MTTs with 119 members. A bipartite network was used to understand 
Selection criteria Characteristic
Research the range of disciplinarity and interconnection of the MTT membership ( Figure 3 ). In this representation, the nodes represent 11 teams and 119 members, and edges between the nodes represent team membership. Th e colors of the nodes represented members' departmental affi liations, and the diameter of each node was proportional to the number of connecting edges, so teams with many members were larger compared to those that had fewer members. Four teams in the center of the network shared four or more members, three teams shared at least two members, and two teams shared no members. Th e shared members were mostly researchers who specialized in methods (e.g., biostatistics, proteomics analysis), or CTSA leadership. Th ree teams were more homogenous in member affi liation compared to the rest. Th e overall observations led to the hypothesis that shared members could enhance interteam exchange of specialized technologies, or acquire new capabilities. Analysis of this network also suggested a correlation between team heterogeneity and the number of shared members. Th is depiction is a snapshot of a dynamic process, and ongoing assessment of our networks in relationship to objective metrics of team productivity will facilitate understanding the critical elements of team structure and function that predict research productivity. Shown is a bipartite network of 11 translational teams and 119 members. The nodes were laid out using the Kamada Kawai algorithm suitable for mid-sized networks in the range of 100 nodes. The algorithm pushes together nodes that share many connections, and pushes apart nodes that do not, resulting in a layout that approximates the relationship between nodes.
MTT-CTSA interactions: Utilization of key resources
the Coordination and Tracking and Evaluation KRs) based on analysis of milestones and outcomes. We examined the utilization of 10 CTSA Key Resources by the 11 MTTs. In this analysis, the nodes represent 11 teams and 10 KRs, and the edges represent the KR utilization ( Figure  5 ). The size of the KR nodes was proportional to the total time spent with each MTT (shown by the thickness of the edges connecting each MTT and KR), plus the total time spent for general activities such as infrastructure building that are useful across MTTs. The thickness of the edges connecting each KR-MTT pair was proportional to the hours reported by each KR in support of the respective MTT. This analysis indicated that KR utilization varied along two dimensions: Frequency and Total Use. For example, the Coordination Core was utilized • Initiation: MTT goals established, and necessary expertise determined
• Team members with expertise in biostatistics, ethics, and informatics were added.
• Expertise in biostatistics, regulatory affairs, ethics, and clinical medicine, and trial design was embedded by all 11 MTTs, but the overall time spent across all MTTs was relatively small. In contrast, the Translational Technologies was used by 7 of the 11 MTTs, but its overall usage across those MTTs was high. Furthermore, there was a set of MTTs and KRs that formed an inner core representing high interaction characteristic of the needs of their translational project at their developmental stage. Projects early in development (Burns) required heavy use of biostatistics for clinical study design, whereas ongoing molecular-based studies (PediatricBronchiolitis, Otitis Media, and Aging) required heavy use of the Translational Technologies KR.
Case illustrations
Two MTTs are described, each entering at distinct developmental stages and requiring diff erent CTSA Key Resources ( Table 6 , c.f. Figure 4 ) .
Th e severe asthma MTT (SA-MTT)
Th e SA-MTT was formed upon CTSA funding by several existing, but independent research groups in airway inflammation. Th e translational goal of the SA-MTT is to develop predictive protein biomarkers to advance personalized medicine in severe asthma. Th e SA-MTT strategic core began with a senior translational investigator as the team leader, a senior basic investigator, and a senior proteomics investigator as collaborating investigators, and a senior fellow in pulmonary medicine as a trainee. Biostatistics and ethics expertise from the CTSA key resources were included on initiation and other collaborators from each of the key areas were also invited to participate. Team meetings were scheduled on a recurring basis twice monthly. Initial work included developing a mutually agreeable team vision and goals, and establishing the framework for a new, multidisciplinary project. Once established, the vision and goals guided the discussion of the details of the project. Leadership development is an explicit goal of the MTT; consequently, we appointed a senior trainee (Clinical Fellow) as the Project Manager, whose responsibilities included confi rming the logistics of meetings, maintaining agreed-upon timelines for completion of work elements, leading team discussions, setting agenda and conducting specifi c aspects of the scientifi c program.
Th e involvement of the CTSA Bioinformatics KR enabled the SA-MTT to identify proteomic signatures that correlate with important physiologic characteristics in asthma (eosinophilia, bronchodilator responsiveness to beta-2 agonists, and methacholine responsiveness), and described four molecular phenotypes in our asthma subjects. Both of these papers were published in high profi le peer-reviewed journals. 58, 59 With a new Bioinformatics resource developed by CTSA funding (the Discovery and Innovation through Visual Analytics Laboratory), the SA-MTT used network analysis to reanalyze the proteomic signature data. Using these powerful approaches, 3 clusters of protein expression were identifi ed, and associated with specifi c phenotypes of asthma, which provided important biological pathway information that was hitherto not evident. Th ese observations have been also published in a high profi le, peer-reviewed journal. 60 Th e impact of the CTSA was evident in that these insights would not otherwise have been generated.
Th e C. diffi cile infection MTT (CDI-MTT)
Th e CDI-MTT represented a new opportunity when a PhD-trained investigator developed compelling new information regarding the molecular mechanisms by which Clostridium diffi cile infection causes colitis. Importantly, these mechanistic insights informed a strategy for developing novel therapeutic agents for this important disease. Th e purpose of the CDI MTT was to develop novel therapeutics strategies for clinical CDI, and test those strategies in appropriately designed clinical trials. However, effi ciently moving the basic science concepts into a clinical realm was outside the current scope of expertise of the PI.
Th e team was initiated with a senior basic science investigator as the team leader, a clinical pathologist, and a gastrointestinal clinician as important members. Biostatistics and ethics expertise were included on initiation. Team meetings were scheduled on a recurring basis twice monthly, using the logistical support of the CTSA. Initial work included developing a mutually agreeable team vision and goals, and establishing the framework for a clinical trial. Once established, the vision and goals guided the discussion of the details of the project. As the planning for an intervention trial in CDI progressed, it became clear that the limited experience of the team with formal clinical trials had resulted in a trial design that failed to consider important complexities of diagnosis, treatment, and trial management.
As delays developed in initiating the trial, the team determined that another appropriate course of action was to expend resources towards developing a metabolomic profi le that might predict recurrence of CDI. Th e development and analysis of a metabolomic dataset from patients with CDI has led to a provisional metabolomic panel which may have predictive capability for recurrence of CDI. In addition the CDI team incorporated a novel method for analysis of S -nitrosylated proteins in host defense to the C. diffi cile enterotoxin that was developed and made available through the Translational Technologies Key Resource. Th is approach enabled the observation that host S -nitrosylation is important in toxin inactivation, and resulted in a major publication 61 that formed the basis for a newly funded RO1. From this experience, we learned that early incorporation of clinical trial expertise in an MTT project that might reasonably progress to a clinical trial within the time frame of the lifecycle of the proposed project would be useful. In addition, early incorporation of regulatory expertise to submit an investigational new drug application could accelerate the process.
Discussion and Lessons Learned
Increasing evidence confi rms that the use of teams in science is productive. 2-4 , 6 As in other disciplines, much can be gained by employing best practices for eff ective team functioning. To achieve this goal, we have applied selected areas of team theory and practice to translational teams supported by an institutional framework, in our case, the CTSA.
Trust amongst team members results in enhanced cooperation and acquisition of shared work values. 64 Team trust coupled with emotional intelligence is promoted by regular interactions, appropriate recognition for team roles established through the formative stages of the MTT life cycle. As a result collaboration and team creativity is enhanced. 65 To operationalize multidisciplinary communication within our SA-MTT, we piloted a communications strategy called "methods intuition. " It had become apparent that team members were not familiar with the views, vocabulary, and common knowledge base of other disciplines within the team. For example, pulmonologist members performed invasive procedures, including bronchoscopy and bronchoalveolar lavage, but other members had such limited knowledge of the details that it inhibited substantive discussion. Analogously, many team members were not conversant in the technical specifi cs of proteomic analysis, or the intricacies of the ethical conduct of human research. Th e language, conceptual frameworks, and work fl ow were foreign. It became essential to develop effective cross-disciplinary communication. Methods intuition focused on educating team members about the discipline-specifi c terminologies used, the technical methodologies employed, and the kinds of inferences that can be drawn from that discipline. 66 Th is activity signifi cantly enhanced intra-team communication and eff ectiveness.
MTT Disciplinarity
Because of the dynamic nature of discipline involvement in MTTs project evolution, we believe that multidisciplinarity is likely to be the most effi cient structure for MTT organization. Our bipartite network depiction of disciplines represented in the UTMB MTTs was initially approached by an analysis of the primary departmental affi liations of the membership. From this analysis, several larger MTTs (aging, obesity) tended to have a more homogenous composition of 3-4 disciplines represented. By contrast, smaller or nascent MTTs (CDI-MTT, SA-MTT) were highly interconnected by several key disciplines. Th ese highly connected components of the network tended to be represented by bioinformatics, and/or CTSA leadership (black circles, Figure 3 ). Th e cross-MTT interactions may be opportunities for collaborations in new research domains. It will be of interest to follow the evolution of these highly connected MTTs to determine their productivity and trajectory.
CTSA impact on MTT innovation
The MTT construct provides its participants with unique opportunities for team science. First, dynamic team-based systems can address the full range of expertise needed to span all phases of the translational domain. It is axiomatic that the full range of skills necessary for translational research spanning the T1-T4 domains is rare in any single investigator. 8 Appropriately composed, the strategic core of an MTT can contain the requisite skill sets for accomplishing T1 objectives, then can reform its skill sets as it transitions into a T2 domain by restructuring the MTT. Another facet of the MTT is enhanced infl uence in distinct disciplines. For example, the CTSA supported bioinformatics enabled the SA-MTT to profi les of asthma phenotypes, contributing research papers in domains that would not have been possible otherwise. The formal MTT method intuition was an intervention to promote improved team communication and eff ectiveness. Th e method intuition approach was been shared throughout the CTSA MTT structure, to promote communication within other MTT strategic cores. Innovation in the CDI-MTT was enhanced by access to novel proteomics technologies that enhanced discovery in mechanisms of host-defense and potential mechanisms for translational therapy.
CTSA-MTT interactions
CTSA Key Resource utilization will depend on the developmental stage of the MTT Project ( Figure 4 ). Hence, we recognize that the network representation of CTSA-MTT interactions is a snapshot of a highly dynamic process. However, this shapshot informs optimal CTSA Key Resource confi guration and size required to support MTT projects. Th e UTMB MTTs are primarily in T1 domain of the translational spectrum. Our analysis suggests that a cluster of Key Resources (biostatistics, translational technologies, and novel methodologies) are heavily involved at present in MTT projects, whereas other Key Resources (education, bioinformatics, CRC) are devoting signifi cant time to the CTSA in terms of infrastructure development. In addition, the larger, independent MTTs from the discipline analysis ( Figure 3 ) tended to consume a small subset of Key Resources. For example, the aging MTT primarily used the CRC and, to a lesser extent, translational technologies. Analysis of network depictions over time will inform dynamic right-sizing of Key Resources as MTT projects evolve into T2 and T3 domain activities.
Education in the MTTs
Training in competencies required for translational research is one of the major goals of MTTs ( Table 4 ). Within MTTs, early stage investigators, including junior faculty, research and clinical fellows, and graduate and medical students, are acquiring the scientifi c knowledge and skills of their individual disciplines, more specifi c skills needed by the MTT, and a broader set of competencies now expected of a translational researcher. Skills and competencies are acquired both from organized learning sessions and from ongoing experience. Th ey are guided in these learning eff orts by primary and secondary mentors who are members of their MTT, by team development coaches embedded in the CTSA, and by other faculty in their own disciplines. Th eir training includes undertaking a major role in a project within the MTT, which for students will relate course work to the scientifi c pursuits of the team. Th ey also gain knowledge and experience in how teams function and learn the benefi ts of structured teamwork. Th ey learn that functioning in a work silo is only one possible future scientifi c careers track, and that team-based science may be more productive. Th ey will incorporate advances in the fi eld of team science and thereby understand that teams are subject to scientifi c study, and that individual activities within teams can be guided in a manner to achieve both scientifi c goals and career advancement. Conversely, they learn that a team project may fail due either to scientifi c issues or from problems with team relationships and functioning.
More generally, an MTT should provide a rich and unique educational environment for members at all levels. Eff ective team collaboration requires that each member learns to acknowledge the contributions of others, becomes conversant with other disciplines within the team, and contributes discipline-specifi c knowledge. If this educational process is successful, all team members are more likely to work eff ectively toward clear and mutually agreed upon scientifi c goals. Th e process of educating each other in some aspects of their individual disciplines, using method intuition or other approaches, not only makes the team more productive, but also broadens scientifi c understanding and professional eff ectiveness of the individual team members. Th us, an MTT is an educational environment where junior and senior members from diff erent disciplines can combine their skills and educate each other as they work on challenging and complex scientifi c problems. Members leaving a team are enriched by a more widely applicable fund of skills and knowledge and are better able to conduct team-related work in the future.
Challenges and ongoing development
Both challenges and opportunities exist in the application of MTTs to translational science in AHCs. Formalized team training and team development increases team eff ectiveness, 24, 67 and enhances innovation on team-based projects. 68 However, teams are somewhat contrary to traditional academic reward structures. Specifi c conceptual models of team maturity and adaptation are required, based on identifying team member skills, understanding development of new skills, metricating individual and team learning, and quantifying productivity. 69, 70 A more prescriptive taxonomy of team based skills that is specifi c to team science would facilitate development of such models,
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but at present no consensus exists on this point. While general competencies have been developed, 14 it will be necessary to defi ne with more specifi city the team-related skills needed for success in both trainees and mature leaders.
Perhaps the greatest challenge involves the evaluation of team science in the context of a complex discipline, translational science. Th is issue is compounded by the fact that the evaluation of team science must occur at multiple levels, to include innovation, productivity, and pace of scientifi c discovery. 1 Not only does team science present multiple evaluative diffi culties, but its study is made more complex in that it must also address a long range clinical continuum representative of translational science, with outcomes that diff er depending on the stage of translation. 71 Th us, team structure, team processes, and team skills must be evaluated at multiple levels over long periods of time. While a suffi cient number of general team eff ectiveness models exist, 26-32 , 34 team eff ectiveness models for translational science will need to be developed.
Strengths and Limitations of the MTT approach
Several strengths of our approach are notable. Clearly, conducting translational research, from T1 to T4, requires skills that are only rarely held by a single investigator, necessitating contributions by multiple investigators in distinct disciplines. In fact, even projects constrained within a single translational dimension are improved by multidisciplinarity. Th e MTT benefi ts both from complementarity of expertise of investigators from diff erent disciplines, which promotes innovation and creativity, and also from overlap of expertise, which provides functional redundancy that reduces the likelihood that a complex project will halt due to the unavailability of a single team member. Goals that are developed and endorsed within the team have broader applicability, and increased signifi cance and impact. Membership from several disciplines makes more likely that multiple publications from a single project, each focused on a particular discipline, will be produced, enhancing productivity. For example, the SA-MTT has publications in clinical immunology, collaborative science, and information manangement journals, at least two of which would not have been written had the team not existed. Th e formal incorporation of trainees and leadership development processes promotes individual career skills development and facilitates the functioning of the team. Project management processes, adapted from the business community, bring temporal and task accountability to the team, avoiding unnecessary delays in the project. Periodic milestone assessment permits the team and its manager to identify bottlenecks and other obstacles, and inform the application of resources to mitigate or eliminate the hindrances. We postulate, but have not yet shown, that these advantages will result in increased innovation, accelerated scientifi c discovery, and faster reduction to practice.
Th e MTT structure does entail increased complexity, and a greater "process focus" than is common in AHC or traditional laboratory groups. Th is increased complexity translates to a greater initial investment of time and intellectual eff ort to instantiate a team and defi ne its project. Confl ict resolution skills, which in an hierarchical group are less frequently required, are not infrequently needed, as a wider variety of stakeholder views must be reconciled. Th ere is a learning curve for senior investigators, accustomed to an autocratic reporting structure, to adapt to a distributed authority model. We anticipate that some investigators may not be able to make this transition eff ectively. Identifying these investigators and developing interventions that improve team skills may have great value to enhance the translational product pipeline.
Summary
Based within an academic healthcare environment with missions to generate knowledge, provide education and training, and care for patients, MTTs are tasked with developing translational products and accelerating the pace of scientifi c discovery that will positively impact human health. In this context, MTTs represent a unique, hybrid form of team organization. In this Special Report, we describe the adaptation of business and organizational principles to the development of MTTs and illustrated how the CTSA structure specifi cally can be used to further this purpose. More work will be required to identify the best mechanisms for fostering transformative leadership, evaluating team performance, and measuring the impact of translational science on human health.
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